Status:
COMPLETED
A Study to Assess the Effect of RO4607381 in Patients With Relatively Low Levels of High Density Lipoprotein-Cholesterol (HDL-C)
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Dyslipidemia
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
This 4 arm study will evaluate the efficacy and safety of RO4607381 when co-administered with pravastatin in patients with low or relatively low HDL-C levels. Patients will be randomised to one of 4 g...
Eligibility Criteria
Inclusion
- adult patients 18-75 years of age;
- dyslipidemic patients with low or relatively low HDL-C levels during treatment with pravastatin.
Exclusion
- women who are pregnant, breastfeeding, or of child-bearing potential;
- morbid obesity;
- uncontrolled hypertension;
- poorly controlled or insulin-treated diabetes;
- high creatinine levels or history of statin-associated myopathy.
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2006
Estimated Enrollment :
292 Patients enrolled
Trial Details
Trial ID
NCT00697203
Start Date
July 1 2005
End Date
May 1 2006
Last Update
January 2 2020
Active Locations (33)
Enter a location and click search to find clinical trials sorted by distance.
1
Mobile, Alabama, United States, 36608
2
Scottsdale, Arizona, United States, 85251
3
Newark, Delaware, United States, 19713
4
Miami, Florida, United States, 33137